STOCK TITAN

Neuraxis (NRXS) investors approve directors, plan changes and ESPP at 2026 meeting

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Neuraxis, Inc. held its annual stockholder meeting, with 10,206,763 votes represented, equivalent to approximately 73.51% of outstanding voting power, establishing a quorum. Six directors were elected, each receiving at least 96.64% of votes cast for their seats.

Stockholders ratified the appointment of Rosenberg Rich Baker Berman, P.A. as independent auditor for the year ending December 31, 2026, with 10,187,191 votes in favor. They also approved an amendment to the 2022 Omnibus Securities and Incentive Plan, which again revised Section 5.1, and approved the Neuraxis, Inc. 2025 Employee Stock Purchase Plan.

Before the meeting, the board amended Section 5(c) of the Employee Stock Purchase Plan so that no employee may receive purchase rights if, immediately after grant, the employee would own 10% or more of the company’s voting power or value, replacing the original 5% limitation.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Common shares outstanding on record date 11,505,421 shares Common stock outstanding and entitled to votes as of April 14, 2026 record date
Series B preferred shares outstanding 3,796,907 shares Series B Preferred Stock outstanding as of April 14, 2026; entitled to 2,378,059 votes
Votes represented at meeting 10,206,763 votes Total votes present in person or by proxy, about 73.51% of outstanding votes
Auditor ratification support 10,187,191 votes for Votes in favor of ratifying Rosenberg Rich Baker Berman, P.A. for fiscal year ending December 31, 2026
Incentive plan amendment support 6,730,816 votes for Votes for amending the 2022 Omnibus Securities and Incentive Plan (Section 5.1)
ESPP proposal support 7,572,343 votes for Votes for the Neuraxis, Inc. 2025 Employee Stock Purchase Plan
ESPP ownership cap after amendment 10% ownership threshold No employee may receive purchase rights if they would own 10% or more of voting power or value
Prior ESPP ownership limit 5% limitation Original Section 5(c) of the ESPP before the board-approved change
quorum financial
"equivalent to approximately 73.51% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum."
A quorum is the minimum number of members needed to officially hold a meeting or make decisions. It ensures that decisions are made with enough participation to represent the group’s interests, much like a majority must be present for a vote to be valid. For investors, understanding quorum is important because it affects when and how important company or organization decisions can be legally made.
broker non-votes financial
"The proposal regarding the amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows ... Broker Non-Votes ... 2,505,866"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
2022 Omnibus Securities and Incentive Plan financial
"Prior to the Annual Meeting, the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (the “Incentive Plan”) had twice been previously amended."
Employee Stock Purchase Plan financial
"The proposal regarding the Neuraxis, Inc. 2025 Employee Stock Purchase Plan was approved as follows"
An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.
independent registered public accounting firm financial
"the appointment of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false 0001933567 0001933567 2026-06-10 2026-06-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): June 10, 2026

 

Neuraxis, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41775   45-5079684

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

11611 N. Meridian St, Suite 330

Carmel, IN 46032

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (812) 689-0791

 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.001 par value   NRXS   NYSE American

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On June 10, 2026, Neuraxis, Inc. (the “Company”) held an annual meeting of stockholders (the “Annual Meeting”) at 11611 N. Meridian Street, Suite 330, Carmel, Indiana 46032.

 

As of the close of business on April 14, 2026, the record date for the Annual Meeting (the “Record Date”), (i) 11,505,421 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”) were outstanding and entitled to 11,505,421 votes, and (ii) 3,796,907 shares of the Company’s Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) were outstanding and entitled to 2,378,059 votes. At the Annual Meeting, a total of 10,206,763 votes, comprised of shares of the Company’s Common Stock and Series B Preferred Stock, equivalent to approximately 73.51% of the outstanding votes, were represented in person or by proxy at the Annual Meeting, constituting a quorum. The matters that were voted upon at the Annual Meeting, and the number of votes cast for or against/withheld, as well as the number of abstentions and broker non-votes, as to such matters, where applicable, are set forth below.

 

1. The six nominees for director were elected to serve a one-year term as follows:

 

Director  Votes For   % Votes For   Votes Withheld   % Votes Withheld 
Brian Carrico   7,676,496    99.68%   24,401    0.32%
Dr. Christopher R Brown   7,637,755    99.18%   63,142    0.82%
Bradley Mitch Watkins   7,480,844    97.14%   220,053    2.86%
Beth Keyser   7,480,517    97.14%   220,380    2.86%
Kristen Ferge   7,442,259    96.64%   258,638    3.36%
Dr. Gilad Aharon   7,676,498    99.68%   24,399    0.32%

 

2. The proposal to ratify the appointment of Rosenberg Rich Baker Berman, P.A. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved as follows:

 

Votes For   Votes Against   Broker Non-Votes   Votes Abstained
10,187,191   2,757   0   16,815

 

3. The proposal regarding the amendment to Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan was approved as follows:

 

Votes For   Votes Against   Broker Non-Votes   Votes Abstained
6,730,816   727,030   2,505,866   243,051

 

Prior to the Annual Meeting, the Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan (the “Incentive Plan”) had twice been previously amended. Each amendment solely related to Section 5.1 of the Incentive Plan. The third amendment to the Incentive Plan approved by the Company’s stockholders at the Annual Meeting also solely related to Section 5.1 of the Plan.

 

The Incentive Plan, as amended and currently in effect following the Annual Meeting, is attached hereto as Exhibit 10.1.

 

4. The proposal regarding the Neuraxis, Inc. 2025 Employee Stock Purchase Plan was approved as follows:

 

Votes For   Votes Against   Broker Non-Votes   Votes Abstained
7,572,343   122,240   2,505,866   6,314

 

The Neuraxis, Inc. 2025 Employee Stock Purchase Plan (the “ESPP”) was filed as an exhibit to a Current Report on Form 8-K filed by the Company on July 3, 2025. Prior to the Annual Meeting, the Board approved changing Section 5(c) of the ESPP so that no employee may receive purchase rights pursuant to the ESPP if, immediately after grant, the employee would own 10% or more of the Company’s voting power or value. The original Section 5(c) of the ESPP had a 5% limitation.

 

 

 

 

The ESPP, as currently in effect following the Annual Meeting, is attached hereto as Exhibit 10.2.

 

Exhibit No.   Description
10.1   Neuraxis, Inc. 2022 Omnibus Securities and Incentive Plan, as amended
     
10.2   Neuraxis, Inc. 2025 Employee Stock Purchase Plan, as amended
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: June 12, 2026 NEURAXIS, INC.
   
  By: /s/ Brian Carrico
  Name: Brian Carrico
  Title: President and Chief Executive Officer

 

 

 

FAQ

What percentage of voting power was represented at Neuraxis (NRXS) 2026 annual meeting?

Neuraxis had approximately 73.51% of outstanding voting power represented at its annual meeting. A total of 10,206,763 votes from common and Series B preferred stock were present in person or by proxy, which constituted a valid quorum for conducting business.

Were all director nominees elected at Neuraxis (NRXS) 2026 annual meeting?

All six Neuraxis director nominees were elected to one-year terms. Each nominee received at least 96.64% of votes cast for their election, with Brian Carrico and Dr. Gilad Aharon each receiving 7,676,498 votes for and only 24,399–24,401 votes withheld.

Did Neuraxis (NRXS) stockholders ratify the 2026 independent auditor?

Stockholders ratified Rosenberg Rich Baker Berman, P.A. as Neuraxis’ independent registered public accounting firm for 2026. The proposal received 10,187,191 votes for, 2,757 votes against and 16,815 abstentions, with no broker non-votes reported on this item.

What changes were approved to the Neuraxis (NRXS) 2022 Omnibus Securities and Incentive Plan?

Stockholders approved a third amendment to the Neuraxis 2022 Omnibus Securities and Incentive Plan, again revising Section 5.1. The proposal received 6,730,816 votes for, 727,030 against, 243,051 abstentions and 2,505,866 broker non-votes, and the amended plan is now in effect.

How did Neuraxis (NRXS) modify its 2025 Employee Stock Purchase Plan ownership limit?

Neuraxis’ board revised Section 5(c) of the 2025 Employee Stock Purchase Plan before stockholder approval. Employees can no longer receive purchase rights if they would own 10% or more of company voting power or value, replacing the prior 5% ownership limitation in that section.

Did Neuraxis (NRXS) stockholders approve the 2025 Employee Stock Purchase Plan?

Yes, stockholders approved the Neuraxis 2025 Employee Stock Purchase Plan. The proposal received 7,572,343 votes for, 122,240 against, 6,314 abstentions and 2,505,866 broker non-votes, and the amended plan is now effective as reflected in Exhibit 10.2.

Filing Exhibits & Attachments

5 documents